Rho kinase inhibitor enables cell-based therapy for corneal endothelial dysfunction
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Rho kinase inhibitor enables cell-based therapy for corneal endothelial dysfunction
Authors
Keywords
-
Journal
Scientific Reports
Volume 6, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-05-18
DOI
10.1038/srep26113
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cell therapy for liver disease: From liver transplantation to cell factory
- (2015) Stuart J. Forbes et al. JOURNAL OF HEPATOLOGY
- The effects of Rho-associated kinase inhibitor Y-27632 on primary human corneal endothelial cells propagated using a dual media approach
- (2015) Gary S. L. Peh et al. Scientific Reports
- Cell-Based Approach for Treatment of Corneal Endothelial Dysfunction
- (2014) Naoki Okumura et al. CORNEA
- Evolution of Endothelial Keratoplasty
- (2013) Francis W. Price et al. CORNEA
- Preclinical Studies for Induced Pluripotent Stem Cell-based Therapeutics
- (2013) John Harding et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Inhibition of TGF-β Signaling Enables Human Corneal Endothelial Cell Expansion In Vitro for Use in Regenerative Medicine
- (2013) Naoki Okumura et al. PLoS One
- Corneal Endothelial Expansion Promoted by Human Bone Marrow Mesenchymal Stem Cell-Derived Conditioned Medium
- (2013) Makiko Nakahara et al. PLoS One
- ROCK Inhibitor Converts Corneal Endothelial Cells into a Phenotype Capable of Regenerating In Vivo Endothelial Tissue
- (2012) Naoki Okumura et al. AMERICAN JOURNAL OF PATHOLOGY
- Graft Rejection and Graft Failure After Penetrating Keratoplasty or Posterior Lamellar Keratoplasty for Fuchs Endothelial Dystrophy
- (2012) Jesper Hjortdal et al. CORNEA
- Evaluation of the use of an induced puripotent stem cell sheet for the construction of tissue-engineered vascular grafts
- (2012) Narutoshi Hibino et al. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
- Hydrogels as feeder-free scaffolds for long-term self-renewal of mouse induced pluripotent stem cells
- (2012) Jing Jing Yang et al. Journal of Tissue Engineering and Regenerative Medicine
- Corneal transplantation
- (2012) Donald TH Tan et al. LANCET
- Risk of Corneal Transplant Rejection Significantly Reduced with Descemet's Membrane Endothelial Keratoplasty
- (2012) Arundhati Anshu et al. OPHTHALMOLOGY
- Balancing Tissue and Tumor Formation in Regenerative Medicine
- (2012) A. M. Bailey Science Translational Medicine
- Incidence of Early Allograft Rejection After Descemet Membrane Endothelial Keratoplasty
- (2011) Isabel Dapena et al. CORNEA
- Graft survival and endothelial outcomes in the new era of endothelial keratoplasty
- (2011) Sanjay V. Patel EXPERIMENTAL EYE RESEARCH
- Proliferative capacity of corneal endothelial cells
- (2011) Nancy C. Joyce EXPERIMENTAL EYE RESEARCH
- Graft Rejection After Descemet's Stripping Automated Endothelial Keratoplasty
- (2011) Jennifer Y. Li et al. OPHTHALMOLOGY
- Cultivation of Human Corneal Endothelial Cells Isolated from Paired Donor Corneas
- (2011) Gary S. L. Peh et al. PLoS One
- Human Corneal Endothelial Cell Expansion for Corneal Endothelium Transplantation: An Overview
- (2011) Gary S. L. Peh et al. TRANSPLANTATION
- Molecular Pathway and Cell State Responsible for Dissociation-Induced Apoptosis in Human Pluripotent Stem Cells
- (2010) Masatoshi Ohgushi et al. Cell Stem Cell
- Graft rejection episodes after Descemet stripping with endothelial keratoplasty: part two: the statistical analysis of probability and risk factors
- (2008) M O Price et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Comparison of Different Adult Stem Cell Types for Treatment of Myocardial Ischemia
- (2008) K. E.A. van der Bogt et al. CIRCULATION
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started